CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...
“The European Medicines Agency might supplant the FDA as the gold standard if the FDA goes off track and is politically ...
The fact that the European Medicines Agency (EMA) advised against conditional approval adds to the cautious approach. Moreover, Agenus’s ongoing investigator-sponsored trials (ISTs) in the neoadjuvant ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
Earlier this year, the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) issued positive opinions for AT-02 for ATTR and light chain (AL) amyloidosis which were adopted by ...
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Interim analysis for Study 1 of Essential3 Phase 3 program for ulixacaltamide in essential tremor (ET) confirmed for Q1 2025; ...